THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
Federal contract awards won by THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER (UEI S3GMKS8ELA16), 2010–2026 — public record from USAspending.
Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
34
awards
$242,133,487
total value
2
agencies
Agencies buying from THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
What THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER sells
541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) (17)541712 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) (6)112990 — ALL OTHER ANIMAL PRODUCTION (2)541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (2)621991 — BLOOD AND ORGAN BANKS (2)541940 — VETERINARY SERVICES (2)541990 — ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES (2)541720 — RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES (1)
Awards
BAA FY26C1FP7 MD ANDERSON ONCOLOGY CENTER FOR EXCELLENCE (OCE), EVALUATING BAYESIAN EFFECTIVE SAMPLE SIZE AND DECISION CRITERIA FOR PEDIATRIC AND RARE DISEASE TRIALS
Department of Health and Human Services · $752,304 · Sep 30, 2026
OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC)
Department of Health and Human Services · $1,578,579 · Sep 1, 2026
BORDETELLA-FREE BABOONS FOR PERTUSSIS INFECTION AND VACCINATION STUDIES
Department of Health and Human Services · $368,627 · Aug 31, 2026
PROJECT TITLE: LOW-DOSE ERLOTINIB AND MESALAMINE FOR PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER (CAC)
Department of Health and Human Services · $691,578 · Sep 25, 2025
BAA-MD ANDERSON-STATISTICAL DESIGNS AND CONSIDERATIONS FOR DOSE OPTIMIZATION FY25C1FP6
Department of Health and Human Services · $1,184,156 · Sep 16, 2025
MED PHYSICS PEER REVIEW SERVICES
Department of Veterans Affairs · $355,700 · Sep 30, 2024
TIME-RESTRICTED FEEDING FOR PANCREATIC CANCER PREVENTION
Department of Health and Human Services · $551,730 · Sep 20, 2024
PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM
Department of Health and Human Services · $149,995,000 · Jan 25, 2024
TARGETING THE A2B ADENOSINE RECEPTOR FOR IMMUNOPREVENTION OF PANCREATIC CANCER
Department of Health and Human Services · $593,572 · Sep 15, 2023
FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION
Department of Health and Human Services · $1,293,012 · Jul 26, 2023
TARGETING DKK1 WITH A DNA VACCINE TO PREVENT DEVELOPMENT OF MULTIPLE MYELOMA
Department of Health and Human Services · $1,101,494 · Jun 26, 2023
TARGETING STAT3 TO PREVENT NON-SMALL CELL LUNG CANCER (NSCLC) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Department of Health and Human Services · $1,097,981 · Sep 15, 2022
RHESUS, INDIAN ORIGIN, EVEN GENDER, - 2 YRS OF AGE, SPF IAW RFQ NC42. (75N98021D00018)
Department of Health and Human Services · $255,965 · Jul 16, 2022
PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS-- TARGETING THE PARP PATHWAY FOR THE PREVENTION OF BREAST CANCER
Department of Health and Human Services · $1,121,090 · Jun 1, 2022
MEDICAL PHYSICS PEER REVIEW OF RADIATION THERAPY QUALITY ASSURANCE OPERATIONS
Department of Veterans Affairs · $662,700 · Sep 30, 2021
IMMUNOGENICITY STUDY IN BABOONS FOLLOWING VACCINATION WITH EXPERIMENTAL ACELLULAR PERTUSSIS VACCINES.
Department of Health and Human Services · $547,054 · Sep 28, 2021
TASK ORDER TITLE: EVALUATION OF REAL-TIME METABOLIC IMAGING BIOMARKERS FOR DETECTION OF PANCREATIC PREMALIGNANT LESIONS
Department of Health and Human Services · $1,166,274 · Sep 16, 2021
TARGETING STAT3 TO PREVENT COLORECTAL CANCER SECONDARY TO INFLAMMATORY BOWEL DISEASE
Department of Health and Human Services · $932,948 · Sep 16, 2021
PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS; TASK ORDER: PREVENTION OF COLORECTAL CANCER WITH IPSC-BASED VACCINE
Department of Health and Human Services · $635,712 · May 12, 2021
OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC)
Department of Health and Human Services · $3,477,589 · Dec 1, 2020
TASK ORDER: PRECLINICAL TESTING OF CD73 INHIBITORS FOR PANCREATIC CANCER IMMUNOPREVENTION
Department of Health and Human Services · $1,191,330 · Sep 21, 2020
BASE:PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY&INTERMEDIATE BIOMARKERS TASK ORDER: TARGETING STAT3 TO PREVENT HEPATOCELLULAR CARCINOMA (HCC) ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH)
Department of Health and Human Services · $843,496 · Jun 1, 2020
NATIONAL CORD BLOOD INVENTORY
Department of Health and Human Services · $30,543,799 · Sep 27, 2019
REPURPOSING OF MACROLIDE ANTIBIOTIC CLARITHROMYCIN FOR THE PREVENTION OF LUNG AND BREAST CANCER
Department of Health and Human Services · $912,585 · Sep 15, 2019
CANCER PREVENTION BY VACCINATION AGAINST INDUCED ANTIGENS
Department of Health and Human Services · $1,227,167 · Sep 15, 2019
Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.
Search open bids